Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A Phase 1 single ascending dose study of pure oral harmine in healthy volunteers

Journal of Psychopharmacology(2024)10.1177/02698811241273772Source: DataRank Database

A Phase 1 single ascending dose study of pure oral harmine in healthy volunteers is a research paper published in Journal of Psychopharmacology (2024). On theSindex it has a DataRank of 0. It has been cited 17 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access17 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 2.86)OA: greenTopics (40)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

L Israël,Olivia Wood ORCID,Usha Govindarajulu ORCID,Rachel T Fremont,Ronjon Banerjee

Live enrichment

PubMed:39301926 PMC:PMC11549898 OpenAlex:https://openalex.org/W4402682742

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: P30 DK020541

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: R01 DK105015

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: R01 DK128242

NIDDK NIH HHS

Grant: R01 DK129196

NIDDK NIH HHS

Grant: P60 DK020541

Wellcome Trust

FWCI

2.86

Citation Percentile

0.9%

Citation Trend

2025

2026

greenLicense: https://journals.sagepub.com/page/policies/text-and-data-mining-license

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11549898/pdf/nihms-2030654.pdf

publisherhttps://journals.sagepub.com/doi/pdf/10.1177/02698811241273772

publisherhttps://journals.sagepub.com/doi/full-xml/10.1177/02698811241273772

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11549898

journalhttps://doi.org/10.1177/02698811241273772

Fields of Study

Synthesis and bioactivity of alkaloidsPsychedelics and Drug StudiesChemical synthesis and alkaloidsHumansHarmineAdultMaleFemaleYoung AdultAdministration, OralMiddle AgedDose-Response Relationship, DrugHallucinogensAdolescentHealthy VolunteersMaximum Tolerated Dose

MeSH Terms

Administration, OralAdolescentAdultDose-Response Relationship, DrugFemaleHallucinogensHarmineHumansMaleMiddle AgedMaximum Tolerated DoseYoung AdultHealthy Volunteers

Keywords

HarmineAyahuascaHarmalineAdverse effectTolerabilityMedicinePharmacologyVomitingNauseaAnesthesiaPhase 1

Sustainable Development Goals

SDG 0: Good health and well-being

A Phase 1 single ascending dose study of pure oral harmine in healthy volunteers

FAIR Checklist

Authors (15)

Funding (7 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)